The money includes $1.4 billion in fines from Eli Lilly, the Indianapolis-based drugmaker, for promoting its antipsychotic drug Zyprexa for non-FDA-approved uses and more than $8.2 million in restitution in connection with an HIV-infusion fraud scheme in Miami.
Meanwhile, the OIG said there cannot be a national adverse event reporting system at this time because of variations in data among the 26 states that would report into the system.
Read the release about OIG healthcare fraud recoveries (pdf).
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
